Informējam, ka Sistēma pielāgota darbam ar interneta pārlūkprogrammu Internet Explorer (8. un jaunākām versijām) un Mozilla Firefox (3.6 un jaunākām versijām).
Izmantojot citu interneta pārlūkprogrammu, brīdinām, ka Sistēmas funkcionalitāte var tikt traucēta.
<p class="MsoBodyText"><span lang="EN-GB">This document provides guidance to manufacturers on the minimum requirements for the lifecycle management of in vitro diagnostic (IVD) medical devices that are developed in preparation for and in response to a public health emergency involving infectious agents requiring immediate availability of authorized IVD devices. </span></p>
<p class="Note"><span lang="EN-GB">NOTE<span style="mso-tab-count: 1;"> </span>This document does not replace existing national (or regional) regulatory pathway requirements for IVD medical devices under non-emergency situations. The regulatory authorization process of emergency use-IVD medical devices is country-specific and it includes:</span></p>
<p class="Note"><span lang="EN-GB">—<span style="mso-tab-count: 1;"> </span>following a risk management process;</span></p>
<p class="Note"><span lang="EN-GB">—<span style="mso-tab-count: 1;"> </span>monitoring the device’s post-market performance and quality assurance;</span></p>
<p class="Note"><span lang="EN-GB">—<span style="mso-tab-count: 1;"> </span>implementing a communication system.</span></p>
Reģistrācijas numurs (WIID)
84816
Darbības sfēra
<p class="MsoBodyText"><span lang="EN-GB">This document provides guidance to manufacturers on the minimum requirements for the lifecycle management of in vitro diagnostic (IVD) medical devices that are developed in preparation for and in response to a public health emergency involving infectious agents requiring immediate availability of authorized IVD devices. </span></p>
<p class="Note"><span lang="EN-GB">NOTE<span style="mso-tab-count: 1;"> </span>This document does not replace existing national (or regional) regulatory pathway requirements for IVD medical devices under non-emergency situations. The regulatory authorization process of emergency use-IVD medical devices is country-specific and it includes:</span></p>
<p class="Note"><span lang="EN-GB">—<span style="mso-tab-count: 1;"> </span>following a risk management process;</span></p>
<p class="Note"><span lang="EN-GB">—<span style="mso-tab-count: 1;"> </span>monitoring the device’s post-market performance and quality assurance;</span></p>
<p class="Note"><span lang="EN-GB">—<span style="mso-tab-count: 1;"> </span>implementing a communication system.</span></p>
